PDCD1 and atherosclerosis: Genetic ablation of PD-1 in atherosclerosis-prone mouse models results in dramatically accelerated lesion development, characterized by enhanced CD8+ T cell infiltration, increased interferon-γ production, and promotion of vulnerable plaque phenotypes with thin fibrous caps and extensive necrotic cores [13].